| Followers | 22 |
| Posts | 2352 |
| Boards Moderated | 1 |
| Alias Born | 09/27/2020 |
Friday, September 20, 2024 1:43:10 AM
The pharmacy tech knew little about the non-mRNA Novavax vaccine, so I spent the time educating her a bit. The information peaked her interest and she stated she was going to research the vaccine more.
I'm looking forward to success of Novavax's Combined Influenza-Covid (CIC) vaccine and plan to get it every year once it completes testing and approval process. Matrix-M adjuvant will help it to succeed where others have failed.
Recent NVAX News
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2025 01:00:22 PM
- Novavax Reports Third Quarter 2025 Financial Results and Operational Highlights • PR Newswire (US) • 11/06/2025 01:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/06/2025 12:47:47 PM
- Novavax Completes U.S. Marketing Authorization Transfer to Sanofi for Nuvaxovid™, Triggering a $25 Million Milestone Payment • PR Newswire (US) • 11/04/2025 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/04/2025 11:02:25 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/30/2025 08:30:19 PM
- Novavax to Report Third Quarter 2025 Financial Results on November 6, 2025 • PR Newswire (US) • 10/30/2025 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/22/2025 11:00:50 AM
- Novavax Executes Planned Site Consolidation, Further Reducing Cost Footprint in Line with Corporate Strategy • PR Newswire (US) • 10/22/2025 11:00:00 AM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 10/14/2025 11:45:27 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/07/2025 11:00:33 AM
- Novavax Continues to Deliver on Sanofi Partnership, Completing Nuvaxovid® EU Marketing Authorization Transfer and Triggering $25 Million Milestone Payment • PR Newswire (US) • 10/07/2025 11:00:00 AM
- Novavax Announces Progress on Sanofi Agreement • PR Newswire (US) • 09/30/2025 01:01:00 PM
- Nuvaxovid® Now Approved in Japan Triggering Takeda Milestone Payment • PR Newswire (US) • 09/04/2025 12:00:00 PM
- Novavax to Participate in the Cantor Global Healthcare Conference • PR Newswire (US) • 09/03/2025 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/27/2025 08:40:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/27/2025 08:38:26 PM
- Novavax's Nuvaxovid™ 2025-2026 Formula COVID-19 Vaccine Approved in the U.S. • PR Newswire (US) • 08/27/2025 07:07:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/21/2025 11:48:52 AM
- Novavax Announces Convertible Debt Refinancing • PR Newswire (US) • 08/21/2025 11:43:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2025 12:04:19 PM
- Novavax Reports Second Quarter 2025 Financial Results and Operational Highlights • PR Newswire (US) • 08/06/2025 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/06/2025 11:47:13 AM
- Novavax to Report Second Quarter 2025 Financial Results on August 6, 2025 • PR Newswire (US) • 07/30/2025 12:00:00 PM
- Novavax's H5N1 Vaccine Candidate Demonstrates Immunogenicity in Preclinical Study • PR Newswire (US) • 07/24/2025 12:00:00 PM
Isiah Thomas Marks Historic Milestone: First NBA Player With Majority Control of a Public Company • OWPC • Nov 6, 2025 12:23 PM
EVTV Takes Flight in Europe: U.S. Heavy-Lift Drones to Disrupt Traditional Vineyard Operations Across Italy • EVTV • Nov 6, 2025 8:19 AM
Avant Technologies Signs Joint Venture to Advance Cell-Based Diabetes Treatment • AVAI • Nov 4, 2025 8:46 AM
ECGI Holdings Signs Binding $30 Million LOI to Acquire Licensed Mortgage Lender RezyFi • ECGI • Nov 3, 2025 8:30 AM
One World Products Secures OEM Approval for Cellulose Fiber-Filled Masterbatch for Future Vehicle Programs • OWPC • Nov 3, 2025 8:15 AM
From Explorer to Producer: The Most Compelling Mining Window • ABMBF • Oct 30, 2025 9:00 AM
